Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryusuke Suzuki

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Journal of Applied Clinical Medical Physics|December 18, 2020
Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomasHideki Minatogawa, Koichi Yasuda, Yasuhiro Dekura, et al.
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Cell Reports|November 23, 2017
Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone RestartTakaaki Watanabe, Michael Marotta, Ryusuke Suzuki, et al.
Cell Death Discovery|June 2, 2026
C/EBPγ induces epithelial-mesenchymal transition and facilitates DNA double-strand break repair in lung adenocarcinoma cellsMinoru Terashima, Ryusuke Suzuki, Kusuma Suphakhong, et al.
Radiation Oncology (London, England)|March 19, 2013
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapyChie Toramatsu, Norio Katoh, Shinichi Shimizu, et al.
Nucleic Acids Research|December 8, 2020
The fragility of a structurally diverse duplication block triggers recurrent genomic amplificationRyusuke Suzuki, Michael M Murata, Nicholas Manguso, et al.
NAR Cancer|April 10, 2024
TDP2 is a regulator of estrogen-responsive oncogene expressionNicholas Manguso, Minhyung Kim, Neeraj Joshi, et al.
Medical Physics|July 5, 2013
Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy: an initial phantom study using patient tumor trajectory dataTaeko Matsuura, Naoki Miyamoto, Shinichi Shimizu, et al.
Medical Physics|September 11, 2012
Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation studyTaeko Matsuura, Kenichiro Maeda, Kenneth Sutherland, et al.
Japanese Journal of Clinical Oncology|June 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY)Kota Kawabata, Koichi Yasuda, Satoaki Nakamura, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Journal of Applied Clinical Medical Physics|December 18, 2020
Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomasHideki Minatogawa, Koichi Yasuda, Yasuhiro Dekura, et al.
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Cell Reports|November 23, 2017
Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone RestartTakaaki Watanabe, Michael Marotta, Ryusuke Suzuki, et al.
Cell Death Discovery|June 2, 2026
C/EBPγ induces epithelial-mesenchymal transition and facilitates DNA double-strand break repair in lung adenocarcinoma cellsMinoru Terashima, Ryusuke Suzuki, Kusuma Suphakhong, et al.
Radiation Oncology (London, England)|March 19, 2013
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapyChie Toramatsu, Norio Katoh, Shinichi Shimizu, et al.
Nucleic Acids Research|December 8, 2020
The fragility of a structurally diverse duplication block triggers recurrent genomic amplificationRyusuke Suzuki, Michael M Murata, Nicholas Manguso, et al.
NAR Cancer|April 10, 2024
TDP2 is a regulator of estrogen-responsive oncogene expressionNicholas Manguso, Minhyung Kim, Neeraj Joshi, et al.
Medical Physics|July 5, 2013
Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy: an initial phantom study using patient tumor trajectory dataTaeko Matsuura, Naoki Miyamoto, Shinichi Shimizu, et al.
Medical Physics|September 11, 2012
Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation studyTaeko Matsuura, Kenichiro Maeda, Kenneth Sutherland, et al.
Japanese Journal of Clinical Oncology|June 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY)Kota Kawabata, Koichi Yasuda, Satoaki Nakamura, et al.
Pageof 11